For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.
Adverse Events Module path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Groups
Study -> Results Section -> Adverse Events Module -> Serious Events
Study -> Results Section -> Adverse Events Module -> Other Events
| Title | Description | Deaths # Affected | Deaths # At Risk | Serious # Affected | Serious # At Risk | Other # Affected | Other # At Risk | View |
|---|---|---|---|---|---|---|---|---|
| Deferasirox | Deferasirox (Novartis Pharma): Treatment period 102 weeks. Starting dose 10mg/kg/day. Up to 30/mg/kg according to dose adjustment table as specified in the protocol | None | None | 1 | 2 | 2 | 2 | View |
| Term | Type | Organ System | Vocab | View |
|---|---|---|---|---|
| back pain | None | Musculoskeletal and connective tissue disorders | MedDRA (Unspecified) | View |
| petechiae | None | Skin and subcutaneous tissue disorders | MedDRA (Unspecified) | View |
| haematoma | None | Vascular disorders | MedDRA (Unspecified) | View |
| thrombophlebitis | None | Vascular disorders | MedDRA (Unspecified) | View |
| fatigue | None | General disorders | MedDRA (Unspecified) | View |
| dyspnea | None | Respiratory, thoracic and mediastinal disorders | MedDRA (Unspecified) | View |
| depression | None | Psychiatric disorders | MedDRA (Unspecified) | View |
| wound | None | Injury, poisoning and procedural complications | MedDRA (Unspecified) | View |
| nausea | None | Gastrointestinal disorders | MedDRA (Unspecified) | View |
| dyspepsia | None | Gastrointestinal disorders | MedDRA (Unspecified) | View |
| abdominal pain upper | None | Gastrointestinal disorders | MedDRA (Unspecified) | View |
| hypertension | None | Vascular disorders | MedDRA (Unspecified) | View |
| emotional distress | None | Psychiatric disorders | MedDRA (Unspecified) | View |
| pain in extremity | None | Musculoskeletal and connective tissue disorders | MedDRA (Unspecified) | View |
| gingival bleeding | None | Vascular disorders | MedDRA (Unspecified) | View |